Movement disorders clinical practice · 2025
Movement Disorders in Neuromyelitis Optica Spectrum Disorder: A Systematic Review.
Систематический обзорСтатьяМетаанализНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Bringel Luciana A F, Lima Pedro L G S B, Rodrigues Pedro V F, Cavalcante Francisco L H B, Pinheiro Amanda R, Saraiva Fabricia M S, Rodrigues Cynthia P, Gonçalves Paulo V S, Melo Leonardo J R A, Camelo-Filho Antônio E, Dutra-Junior Avelino M, Veras Samuel R O, Carvalho Fernanda M M, Rolim Flávia P S, Martins Gabriela J, D'Almeida José A C, Braga-Neto Pedro, Pitombeira Milena S, Nobrega Paulo R
Аннотация
BACKGROUND: Several movement disorders (MD) have been reported to occur in neuromyelitis optica spectrum disorder (NMOSD). No extensive review has addressed the whole spectrum of MD in NMOSD.
OBJECTIVE: This article aims to review MD in NMOSD, describing its prevalence and features.
METHODS: A systematic review and prevalence meta-analysis were conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) reporting guidelines. We included articles on NMOSD patients with MD as defined by the 2015 international consensus criteria. Meta-analysis was considered feasible if the prevalence of certain MDs was evaluated for at least 4 studies with more than 5 patients.
RESULTS: Ninety-six articles were selected from an initial pool of 5441, involving 1751 patients, of whom 487 had MD. The prevalence of anti-aquaporin-4 antibodies (AQP4-IgG) was 79.9% in general and 78.7% in NMOSD-MD patients. Tonic spasms/paroxysmal dystonia and ataxia were the most prevalent MD in NMOSD, with 39% and 26% prevalence, respectively. Tremor, parkinsonism, myoclonus, chorea, and other hyperkinetic disorders were more rarely reported.
CONCLUSIONS: A wide range of MDs in NMOSD were found, each with distinct features and frequency in literature. This knowledge might help to identify patients with NMOSD, which presents MD as a clinical feature and improves outcomes.
OBJECTIVE: This article aims to review MD in NMOSD, describing its prevalence and features.
METHODS: A systematic review and prevalence meta-analysis were conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) reporting guidelines. We included articles on NMOSD patients with MD as defined by the 2015 international consensus criteria. Meta-analysis was considered feasible if the prevalence of certain MDs was evaluated for at least 4 studies with more than 5 patients.
RESULTS: Ninety-six articles were selected from an initial pool of 5441, involving 1751 patients, of whom 487 had MD. The prevalence of anti-aquaporin-4 antibodies (AQP4-IgG) was 79.9% in general and 78.7% in NMOSD-MD patients. Tonic spasms/paroxysmal dystonia and ataxia were the most prevalent MD in NMOSD, with 39% and 26% prevalence, respectively. Tremor, parkinsonism, myoclonus, chorea, and other hyperkinetic disorders were more rarely reported.
CONCLUSIONS: A wide range of MDs in NMOSD were found, each with distinct features and frequency in literature. This knowledge might help to identify patients with NMOSD, which presents MD as a clinical feature and improves outcomes.